Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

MorphoSys AG

Start price
Target price
Perf. (%)
€16.57
05.09.22
-
05.10.26
293.97%
11.03.24

Probably not worthwhile Investment
buy
Porsche Automobil Holding SE

Start price
Target price
Perf. (%)
€69.70
05.09.22
€59.00
05.09.23
-24.68%
22.03.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
negative Cash Flow expected
Bad rating
buy
Solaredge Technologies Inc

Start price
Target price
Perf. (%)
€266.35
05.09.22
€300.00
05.09.23
16.01%
17.09.22

High Investments for future growth
Leading role in innovation
Differentiated customer and product portfolio
Sustainability is very important
buy
Rock Tech Lithium Inc.

Start price
Target price
Perf. (%)
€2.62
05.09.22
€4.00
05.09.23
-6.88%
17.09.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Immobiliere Frey

Start price
Target price
Perf. (%)
€33.60
05.09.22
€15.00
05.09.23
2.38%
17.09.22

Could be worthwhile Investment >10% per year
buy
Blue Apron Holdings Inc.

Start price
Target price
Perf. (%)
€67.61
05.09.22
€336.00
05.09.23
-3.83%
19.09.22

Could be very worthwhile Investment >20% year
buy
SNDL Inc.

Start price
Target price
Perf. (%)
€2.67
05.09.22
-
07.11.24
-21.38%
02.06.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Top 10 in its market
Novacyt S.A.

Start price
Target price
Perf. (%)
€1.06
05.09.22
-
05.09.23
-46.97%
24.04.23

Probably not worthwhile Investment
buy
Uniper SE

Start price
Target price
Perf. (%)
€5.18
05.09.22
-
05.09.23
-25.56%
17.09.22

Capable Management
Could be worthwhile Investment >10% per year
Few uniques
High valuation
buy
cyan AG

Start price
Target price
Perf. (%)
€1.89
05.09.22
-
05.09.23
20.42%
06.09.22

Probably not worthwhile Investment
buy
China SXT Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.19
05.09.22
-
05.09.23
-90.57%
06.09.23

Revenue growth >5% per year expected
Probably not worthwhile Investment
buy
Storytel Ab

Start price
Target price
Perf. (%)
€3.98
05.09.22
-
05.09.23
18.75%
10.11.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
buy
ShiftPixy Inc.

Start price
Target price
Perf. (%)
€13.48
05.09.22
-
05.09.23
113.53%
09.09.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
buy
Allakos Inc

Start price
Target price
Perf. (%)
€4.72
04.09.22
-
04.09.23
-13.68%
02.04.23

Risky Investment
buy
Rubius Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.14
04.09.22
-
04.09.23
-92.50%
05.09.23

Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.12
04.09.22
-
04.09.23
-11.64%
15.10.22

Could be worthwhile Investment >10% per year
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.63
04.09.22
-
04.09.23
-6.99%
18.09.22

Could be worthwhile Investment >10% per year
buy
Stellantis N.V.

Start price
Target price
Perf. (%)
€13.18
04.09.22
-
04.09.23
7.04%
10.11.22

Could be worthwhile Investment >10% per year
Farfetch Ltd

Start price
Target price
Perf. (%)
€9.52
04.09.22
€5.00
04.09.23
10.78%
17.09.22

Revenue decline/stagnation expected
Very low/no dividend yield expected
very negative Cash Flow expected
High risks in the balance sheet
First Hydrogen Corp.

Start price
Target price
Perf. (%)
€3.82
04.09.22
€1.00
04.09.23
-7.33%
17.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
overvalued
buy
Allakos Inc

Start price
Target price
Perf. (%)
€4.72
04.09.22
€12.00
04.09.23
-2.53%
17.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Atlanticus Holdings Corp

Start price
Target price
Perf. (%)
€32.40
04.09.22
€11.00
04.09.23
-
17.09.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Mastercard Inc. A

Start price
Target price
Perf. (%)
€327.80
04.09.22
€350.00
04.09.23
4.06%
01.12.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Future proof or reliable business model
buy
Mastercard Inc.

Start price
Target price
Perf. (%)
€16.20
04.09.22
€18.00
04.09.23
4.32%
25.01.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Apple Inc.

Start price
Target price
Perf. (%)
€157.00
04.09.22
€150.00
04.09.23
3.69%
19.05.23

positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital